Gram-Positive Culture Control Panel Supply

The contract seeks the supply of Gram-positive culture control panel kits designed for microbiological quality control testing, encompassing the full lifecycle of manufacturing, packaging, and timely delivery of diagnostic control materials. These kits are critical for ensuring the accuracy and reliability of laboratory testing procedures, particularly in environments requiring strict microbial identification and validation standards. The work is to be performed at Fort Bragg, North Carolina, with a specified delivery location tied to this site, and the procurement is structured as a subcontract under the Department of Defense’s Medical Supply Chain MD Surg FSF. The NAICS code 325414 indicates that the supplier must operate within the pharmaceutical and biological manufacturing sector, adhering to industry-specific quality and compliance benchmarks. Responses are due by May 6, 2026, following the public posting of the solicitation on April 30, 2026. The procurement is not set aside for any specific small business category, and no point of contact details have been provided, suggesting bidders should reference the official DIBBS platform at the specified link for submission instructions and further technical requirements. The focus is on securing a reliable source of standardized control panels that meet rigorous military and medical diagnostic needs, with an emphasis on consistent performance, traceability, and regulatory alignment for use in clinical and field testing environments.